ICH

INTERACT3 Trial: ICU care bundle in acute ICH

INTERACT3 Trial Summary Background: Methods: Findings: Primary Outcome: Interpretation: Trial Information: Key Takeaways: Source

TICH-2 Trial Summary: Tranexamic acid for IntraCerebral Haemorrhage

2018 TICH-2 TRIAL Tranexamic acid for hyperacute primary intracerebral haemorrhage Double blind, randomised, placebo-controlled, phase 3 superiority trial Objective: To assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage 3 2325 … Read More